Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0013 USD
Change Today 0.00 / 0.00%
Volume 0.0
OPGX On Other Exchanges
As of 8:10 PM 06/26/15 All times are local (Market data is delayed by at least 15 minutes).

optigenex inc (OPGX) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/22/14 - $0.05
52 Week Low
06/26/15 - $0.0013
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OPTIGENEX INC (OPGX)

Related News

No related news articles were found.

optigenex inc (OPGX) Related Businessweek News

No Related Businessweek News Found

optigenex inc (OPGX) Details

Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging. It serves manufacturers, distributors, and retailers worldwide in the dietary supplement, as well as anti-aging topical skin care, cosmetic, and cosmeceutical market categories. The company is headquartered in Hoboken, New Jersey.

optigenex inc (OPGX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

optigenex inc (OPGX) Key Developments

Optigenex Inc. Reports Positive Results from Double-Blind, Placebo Controlled Study of Onnit Labs Product, AlphaBrain with Ac-11

Optigenex Inc. announced the results of a pilot study entitled A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of AlphaBrain(TM) administered orally, conducted by the Boston Center for Memory. The purpose of the study was to test the efficacy of AlphaBrain(TM) with ac-11(R) as an enhancer of cognitive ability, including memory, attention, problem solving and reasoning. Developed by Optigenex, AC-11(R) is a patented, all natural rain forest botanical extract shown to help the body's natural ability to repair damaged DNA. The Onnit-sponsored study, which utilized a methodology and study design similar to that applied in new drug evaluations, but not often used in research to evaluate dietary supplements, demonstrated statistically significant improvements in areas related to memory and "executive function" (e.g., reasoning and problem solving) among the test subject volunteers taking AlphaBrain(TM) with ac-11(R).


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPGX:US $0.00 USD 0.00

OPGX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OPGX.
View Industry Companies

Industry Analysis


Industry Average

Valuation OPGX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPTIGENEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at